Seroprevalence of mumps and its association with some social determinants in Manisa Province, 2014
Abstract
Aims: The aim of this study was to determine the seroprevalence of mumps and its association with some social determinants of health in the Manisa Province. Method: A random sample of individuals, aged two years and over, from the Manisa Province was included in this cross-sectional study (n=1740). Individuals were interviewed and blood samples were taken in family health centres. Specific antibodies were analysed using the anti-mumps virus ELISA IgG test and values of ≥22 IU/mL were considered as positive. Results: Overall mumps seropositivity was found to be 80.3%. Furthermore, seropositivity was 72.5% for ages 2-19 and 83.1% for ages over 20 (p<0.01). The Odds Ratio of mumps seropositivity was 1.42 (0.94-2.08) for people who had an annual equivalent income per capita of more than 5692 TL; and OR = 1.23 (0.54-2.82) for people who were living in homes which had fewer than one person per room. Conclusions: In all age groups, there is between 10-20% of the population sensitive to the risk of a mumps epidemic. There is no statistically significant association between mumps seropositivity and social determinants. For a successful mumps control program, high vaccine coverage should be aimed and maintained.
Keywords
References
- Reference1 Leland DS. Parainfluenza and Mumps Viruses. In: Jorgensen JH, Carroll KC, Funke Guido, Pfaller MA, Landry ML, Richter SS, Warnock DW editors. Manual of Clinical Microbiology 11th ed.Murray PR, Baron EJ. Manual of clinical microbiology. Washington, D.C.: ASM Press; 2007. p. 1487-97.
- Reference2 Roush SW, McIntyre L, Baldy LM. Manual for the surveillance of vaccine-preventable diseases. Atlanta Dep Health Hum Serv. 2008.
- Reference3 Shanley JD. The resurgence of mumps in young adults and adolescents. Cleve Clin J Med. 2007;74:42-4, 47-8.
- Reference4 Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47: 1458-67.
- Reference5 Greenland K, Whelan J, Fanoy E et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine. 2012;30:4676-80.
- Reference6 Choi KM. Reemergence of mumps. Korean J Pediatr. 2010;53:623-8.
- Reference7 Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371:932-44.
- Reference8 Özmert EN. Dünya'da ve Türkiye'de aşılama takvimindeki gelişmeler. Çocuk Sağlığı ve Hastalık Derg. 2008;51:168-75.
- Reference9 McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1-34.
- Reference10 Elias P. Occupational classification (ISCO-88): Concepts, methods, reliability, validity and cross-national comparability. OECD Publishing; 1997.